Notice: This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsHeadlinesInsider TradesOwnershipTrends Institutional Ownership Changes (13F Filings) for Vaccitech (NASDAQ:VACC)CurrentInstitutional OwnershipPercentage26.13%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$12.37MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$14.76K Get VACC Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccitech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VACC Institutional Buying and Selling by Quarter Ad Investors AlleyStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!Click here to see this breakthrough before everyone else → Vaccitech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024 M&G Plc5,197,349$25.99M0.2%N/A13.483% 1/31/2024 Ipswich Investment Management Co. Inc.23,075$115K0.0%-14.8%0.060% 11/8/2023 Janney Montgomery Scott LLC15,008$46K0.0%N/A0.039% 5/15/2023 Liontrust Investment Partners LLP455,848$1.02M0.0%-24.0%1.189% 4/24/2023 Ipswich Investment Management Co. Inc.27,075$61K0.0%+26.7%0.071% 11/16/2022 Alphabet Inc.1,513,644$4.84M0.2%N/A4.058% Get the Latest News and Ratings for VACC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccitech and its competitors with MarketBeat's FREE daily newsletter. 11/1/2022M&G Investment Management Ltd.5,197,349$15.59M0.1%+377.4%13.964% 10/11/2022 Ipswich Investment Management Co. Inc.23,475$75K0.0%-41.3%0.063% 7/26/2022 Ipswich Investment Management Co. Inc.39,975$178K0.1%-23.7%0.107% 2/14/2022 Johns Hopkins University107,968$1.20M0.1%N/A0.310% 2/14/2022ETF Managers Group LLC10,087$108K0.0%-21.9%0.029% 11/22/2021 Liontrust Investment Partners LLP600,000$9.44M0.1%N/A1.720% 11/16/2021Brookfield Asset Management Inc.15,921$251K0.0%-36.3%0.046% 11/15/2021 Tudor Investment Corp Et Al378,260$5.73M0.0%-10.0%1.102% 11/15/2021 Caas Capital Management LP10,251$161K0.0%-79.5%0.030% 11/12/2021 Ghisallo Capital Management LLC20,625$325K0.0%+106.3%0.060% 10/7/2021 Ipswich Investment Management Co. Inc.51,475$810K0.2%+18.9%0.150% 8/23/2021 DC Funds LP642,204$10.78M51.2%N/A1.871% 8/17/2021Brookfield Asset Management Inc.25,000$420K0.0%N/A0.073% 8/17/2021 Millennium Management LLC130,137$2.18M0.0%N/A0.379% 8/17/2021 Caas Capital Management LP50,000$839K0.0%N/A0.146% 8/16/2021 Squarepoint Ops LLC25,000$420K0.0%N/A0.073% 8/16/2021M&G Investment Management Ltd.1,088,597$18.51M0.0%N/A3.171% 8/16/2021 Cubist Systematic Strategies LLC11,562$194K0.0%N/A0.034% 8/16/2021 Tudor Investment Corp Et Al420,319$6.02M0.1%N/A1.224% 8/12/2021 Monashee Investment Management LLC132,184$2.22M0.3%N/A0.385% 8/11/2021 Arena Capital Advisors LLC CA30,698$515K0.0%N/A0.089% (Data available from 1/1/2016 forward) VACC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VACC shares? During the previous two years, the following institutional investors and hedge funds held shares of Vaccitech shares: M&G Plc ($25.99M), Liontrust Investment Partners LLP ($1.02M), and Ipswich Investment Management Co. Inc. ($115K), Janney Montgomery Scott LLC ($46K).Learn more on VACC's institutional investors. What percentage of Vaccitech stock is owned by institutional investors? 26.13% of Vaccitech stock is owned by institutional investors. Learn more on VACC's institutional investor holdings. Which institutional investors have been buying Vaccitech stock? The following institutional investors have purchased Vaccitech stock in the last 24 months: M&G Plc ($5.20M), Janney Montgomery Scott LLC ($15.01K), and Ipswich Investment Management Co. Inc. ($5.70K). How much institutional buying is happening at Vaccitech? Institutional investors have bought a total of 5,218,057 shares in the last 24 months. This purchase volume represents approximately $12.43M in transactions. Which Vaccitech major shareholders have been selling company stock? The following institutional investors have sold Vaccitech stock in the last 24 months: Liontrust Investment Partners LLP ($144.15K), and Ipswich Investment Management Co. Inc. ($4K). How much institutional selling is happening at Vaccitech? Institutional investors have sold a total of 148,152 shares in the last 24 months. This volume of shares sold represents approximately $337.66K in transactions. Related Companies scPharmaceuticals Institutional Ownership Verastem Institutional Ownership Heron Therapeutics Institutional Ownership Gossamer Bio Institutional Ownership Eledon Pharmaceuticals Institutional Ownership Nanobiotix Institutional Ownership Atossa Therapeutics Institutional Ownership Galectin Therapeutics Institutional Ownership DiaMedica Therapeutics Institutional Ownership Incannex Healthcare Institutional Ownership This page (NASDAQ:VACC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
